Top Section/Ad
Top Section/Ad
Most recent
Cell and gene therapy company plans US expansion
More articles/Ad
More articles/Ad
More articles
-
Nordic ECM has had a more positive start to 2024 than 2023, with over $2.6bn raised via 43 deals -
CPI in the UK held steady in January, raising hopes for rate cuts by the Bank of England
-
Sale ends Kemira's century-long relationship with the state of Finland
-
A blistering rally of equities since the end of 2023 is driving a recovery in EMEA ECM
-
Tuesday night's two-legged share sale was one of the year's biggest blocks in Europe
-
German privatisation is the largest block in EMEA since last year
